CJC-1295 research guide for Coplay. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
For anyone in Coplay trying to locate CJC-1295, the key fact to understand is that this compound moves through online research channels. This online-only market structure is actually an advantage for quality — top vendors compete on lab-verified purity in ways no local retailer can match. Separating properly characterised CJC-1295 from the rest of the market requires three things: an HPLC chromatogram showing ≥98% purity, mass spec data verifying the correct molecular weight, and a batch-specific endotoxin panel. The sections below cover what Coplay researchers need to know about sourcing, verifying, and handling CJC-1295 for scientific research use.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Coplay studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
CJC-1295 Purchasing Guide
The most effective path to quality CJC-1295 is community research first — peptide forums aggregate real purchasing experience that are more reliable than search results. Endotoxin testing in the COA is non-negotiable for any injectable research use — endotoxins from microbial contamination can trigger severe inflammatory responses even at trace quantities. For Coplay researchers evaluating vendors with limited track records: a modest first purchase to test the product before scaling up your order is what experienced peptide researchers consistently do. Price is an poor proxy for CJC-1295 quality — research-grade synthesis and testing has genuine production costs that cannot be cut without consequences, so unusually low prices consistently indicate quality reductions.
Order CJC-1295 — ships to Coplay
COA-verified · International tracking · Research grade
CJC-1295 operates outside approved pharmaceutical regulation — researchers should understand that the risk characterisation for this compound is based on academic studies rather than pharmaceutical approval data. Storage requirements for CJC-1295: lyophilised powder at −20°C, reconstituted solution refrigerated at 2-8°C and finished within 30 days of reconstitution; reconstitute only with sterile bacteriostatic water. Endotoxin testing in the CJC-1295 COA is not optional — gram-negative bacterial endotoxins can trigger serious inflammatory reactions at very low concentrations, and no discount compensates for this missing data. For any individual considering CJC-1295 outside a formal research context: speak with a healthcare professional — this compound is not a licensed human medication and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
